Assets | |||
Property, plant and equipment | 7 | ||
Intangible assets | 8 | ||
Investment property | 9 | ||
Other investments | 10 | ||
Egyéb hosszú lejáratú eszközök | 26 | ||
Deferred tax assets | 24 | ||
Total non-current assets | |||
Inventories | 11 | ||
Trade and other financial receivables | 12 | ||
Other non-financial assets and receivables | 12 | ||
Nyereségadó követelés | 24 | ||
Cash and cash equivalents | 13 | ||
Total current assets | |||
Total assets | |||
Equity and liabilities | |||
Share capital | 14 | ||
Treasury shares | 14 | - | - |
Retained earnings | 14 | ||
Total equity | |||
Loans and borrowings | 16,29 | ||
Deferred tax liabilities | 24 | ||
Provisions | 15 | ||
Other non-current liabilities | 17 | ||
Total non-current liabilities | |||
Provisions | 15 | ||
Current portion of loans and borrowings | 16 | ||
Trade and other financial liebilities | 17,29 | ||
Other non-financial liabilities | 17 | ||
Income tax liability | 24 | ||
Total current liabilities | |||
Total equity and liabilities |
Note | |||
Revenue | 19 | ||
Cost of sales | 20 | - | - |
Gross profit | |||
Selling and marketing expenses | 20 | - | - |
General and administrative expenses | 20 | - | - |
Other income | 22 | ||
Other expenses | 22 | - | - |
Impairment loss on trade receivables and contract | |||
assets | 22 | - | - |
Total other operating expenses | - | - | |
Operating profit | |||
Finance income | 23 | ||
Finance costs | 23 | - | - |
Net finance income/ costs | - | ||
Profit before tax | |||
Taxation | 24 | - | - |
Profit for the year | |||
Total comprehensive income for the year | |||
Basic earnings per share (HUF) | 27 | ||
Diluted earnings per share (HUF) | 27 |
Other | ||||||
comprehensive | ||||||
Share capital | Treasury shares | Retained earnings | income | Total equity | ||
Balance at 1 January 2023 | - | |||||
Profit for the year | ||||||
Balance at 31 December 2023 | - | |||||
Profit for the year | ||||||
Balance at 31 December 2024 | - |
Consolidated Statement of Cash Flows | |||
31 December | 31 December | ||
2023 | 2024 | ||
Cash flows from operating activities | |||
Profit before tax | |||
Adjustments for non-cash items: | |||
Effect of revaluation of FX cash and cash equivalents | 23 | - | |
Interest income | 12 | - | |
Interest expenses | 17 | ||
Depreciation and amortization | 7,8 | ||
Impairment and scrapping of intangible assets, property, plant and equipment | 22 | ||
Allowance for bad and doubtful debts | 12, 26 | ||
Impairment, scrapping of inventories carried at net realisable value | 11 | ||
Changes in provisions | 15 | - | |
Gain or loss on sale of property, plant and equipment and intangible assets | 22 | - | |
Gain or loss on acquisition of subsidiaries, share of profit or loss of associate | |||
Period-end revaluation of loans | 16, 23 | - | |
Changes in working capital: | |||
Changes in trade and other receivables | 12 | - | |
Changes in inventories | 11 | ||
Changes in trade and other liabilities as well as in other non-current liabilities | 18 | - | - |
Taxes paid | 24 | - | - |
Interest paid | 23 | - | - |
Net cash from / used in operating activities | - | ||
Cash flows from investing activities | |||
Acquisition of property, plant and equipment and intangible assets | 7,8 | - | - |
Proceeds from sale of property, plant and equipment and intangible assets | 22 | ||
Acquisition of subsidiary, net of cash acquired | 6, 10 | - | - |
Interest received | 23 | ||
Net cash used in investing activities | - | - | |
Cash flows from financing activities | |||
Loans and borrowings | 16 | ||
Repayment of loans and borrowings | 16 | - | - |
Dividends paid | |||
Net cash from / used in financing activities | - | ||
Net increase/decrease in cash and cash equivalents | - | - | |
Cash and cash equivalents at 1 January | |||
Changes in cash and cash equivalents | - | - | |
Effect of revaluation of FX cash and cash equivalents | - | ||
Cash and cash equivalents at 31 December |